BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GENEWIZ, Inc. Announces CLIA Certification


6/18/2012 9:49:52 AM

SOUTH PLAINFIELD, NJ--(Marketwire - June 18, 2012) -

GENEWIZ, Inc., leading global DNA service provider, received Clinical Laboratory Improvement Amendments (CLIA) Licensure and Certificate of Registration from the State of New Jersey.

CLIA certification marks the milestone expansion of GENEWIZ solutions to include clinical genomic testing, thus contributing to advancements in personalized medicine. Beyond the Kras and EGFR tests, GENEWIZ intends to continue development of additional CLIA-certified assays through utilization of both traditional platforms and new cutting edge technologies, such as next generation sequencing.

"With CLIA registration, GENEWIZ now has the capacity to provide comprehensive solutions for clients working in clinical environments," stated Conrad Leung, Vice President, GENEWIZ, Inc. "We are committed to providing clinical researchers, physicians, and patients with genomic testing results that ultimately lead to better diagnoses and more effective treatments."

To support the growth of clinical genomic testing, GENEWIZ recently expanded laboratory operations at their Global Headquarters in South Plainfield, NJ to include a clean suite dedicated to the processing of clinical and pre-clinical samples. This laboratory enables GENEWIZ to provide expanded services in the areas of biologic drug and cell bank characterization testing, clinical trial investigations, and clinical diagnostic testing.

About GENEWIZ, Inc.
GENEWIZ, Inc. is a global contract research organization (CRO) specializing in DNA-based services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GLP/cGMP regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.

Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; San Diego, CA; Washington, DC Metro; Research Triangle Park, NC; and Seattle, WA. International locations include Beijing, China; Suzhou, China; and London, United Kingdom.


Amy Liao, Ph.D.
COO & President
Email Contact

GENEWIZ, Inc.
115 Corporate Boulevard
South Plainfield, NJ 07080
1-877-GENEWIZ (436-3949)
www.genewiz.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES